CSAM Health - Initiation of coverage - Mission-critical software leader
CSAM Health (CSAM) is a leading provider of specialist healthcare software in the Nordics. Through its mission-critical offering, attractive underlying market, and solid M&A track record, we expect CSAM to be positioned for continued organic growth and increased profitability. We believe this is not priced in, and thus initiate coverage with a BUY and NOK50 target price. Moreover, we see further upside potential if the company executes on its stated M&A strategy.
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.